Interactions

Drug-Drug

• Concurrent use with strong inducers of the UGT A1A enzyme system including rifampin may blood levels and effectiveness.

• Concurrent use with strong inhibitors of the UGT A1A enzyme system may blood levels.

• risk of rhabomyolysis/myopathy HMG-CoA reductase inhibitors

raltegravir is a sample topic found in Davis's Drug Guide. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".

To find other Davis's Drug Guide topics, please login or purchase a subscription.